Chi-Han Li
Overview
Explore the profile of Chi-Han Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
275
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang I, Lin I, Liang Y, Lin J, Chen T, Chen Z, et al.
Bioeng Transl Med
. 2022 May;
7(2):e10267.
PMID: 35600649
Menopausal syndrome includes the symptoms that most women experience owing to hormone changes after menopause. Although hormone replacement therapy is a common treatment for menopausal syndrome, there are still many...
2.
Yang I, Kuan C, Chen Z, Li C, Chi C, Lin Y, et al.
Mater Today Bio
. 2022 May;
15:100266.
PMID: 35517579
Several studies have focused on using cell carriers to solve the problem of mesenchymal stem cell expansion on regenerative medicine. However, the disadvantages of using prolonged enzymatic treatment and low...
3.
Li C, Yang I, Ke C, Chi C, Matahum J, Kuan C, et al.
Front Bioeng Biotechnol
. 2022 May;
10:875069.
PMID: 35497336
Tissue engineered cultured meat has been proposed as an emerging innovative process for meat production to overcome the severe consequences of livestock farming, climate change, and an increasing global population....
4.
Kuan C, Lin Y, Yang I, Chen C, Chi C, Li C, et al.
Front Bioeng Biotechnol
. 2021 Dec;
9:765630.
PMID: 34869278
Body sculpture is a common method to remove excessive fat. The diet and exercise are the first suggestion to keep body shape; however, those are difficult to keep adherence. Ultrasound...
5.
Loong J, Wong T, Tong M, Sharma R, Zhou L, Ng K, et al.
J Clin Invest
. 2021 Apr;
131(11).
PMID: 33878034
Rapidly growing tumors often experience hypoxia and nutrient (e.g., glucose) deficiency because of poor vascularization. Tumor cells respond to the cytotoxic effects of such stresses by inducing molecular adaptations that...
6.
Dong G, Ma T, Li C, Chi C, Su C, Huang C, et al.
Turk J Med Sci
. 2020 Apr;
50(5):1444-1453.
PMID: 32252500
Background/aim: Drynaria fortunei (Gusuibu; GSB) is a popular traditional Chinese medicine used for bone repair. An increasing number of studies have reported that GSB induces osteogenic differentiation in bone marrow...
7.
Liu B, Wu W, Lin M, Li C, Jiang B, Wu S, et al.
Toxins (Basel)
. 2018 Jan;
10(1).
PMID: 29295601
Assessing the neutralization capability of nonlethal but medically relevant toxins in venom has been a challenging task. Nowadays, neutralization efficacy is evaluated based simply on the survival rates of animals...
8.
Lai I, Lai G, Chow J, Lee H, Yeh C, Li C, et al.
Chin Med
. 2017 Nov;
12:33.
PMID: 29177004
Background: The non-small cell lung cancer (NSCLC) is the leading cause of cancer death worldwide. In NSCLC, the oncogenic AKT-mTOR, ERK and STAT3 pathways are commonly dysregulated and have emerged...
9.
Li C, Xiao Z, Tong J, To K, Fang X, Cheng A, et al.
Int J Cancer
. 2016 Sep;
140(1):120-129.
PMID: 27594424
MicroRNA-34a (miR-34a) is frequently downregulated in pancreatic ductal adenocarcinoma (PDAC) cells, however, the silencing mechanism remains unclear. Enhancer of zeste homolog 2 (EZH2) is overexpressed in PDAC, and our previous...
10.
Wong S, Zhang X, Zhuang J, Chan H, Li C, Leung G
Anticancer Res
. 2012 Jul;
32(7):2835-41.
PMID: 22753745
Background: Glioblastoma multiforme (GBM) is a form of highly malignant brain tumour. Temozolomide (TMZ) is the standard agent for GBM, but TMZ-resistance is common and accounts for many treatment failures....